Dietmar Waitz

<i>O</i>-(2-¹⁸F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma

Markus Hutterer, Martha Nowosielski, Daniel Putzer et al. · Journal of Nuclear Medicine · 2011 · 167 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine

Alexander Kroiss, Daniel Putzer, Christian Uprimny et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 123 citations

Medicine, Nuclear Medicine, Oncology +13

68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT

Alexander Kroiss, Daniel Putzer, Clemens Decristoforo et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 106 citations

Medicine, Nuclear Medicine, Oncology +17

Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle

Bernhard Nilica, Dietmar Waitz, Vlado Stevanovic et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 93 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients.

Michael Gabriel, Ulrich Andergassen, Daniel Putzer et al. · PubMed · 2010 · 66 citations

Medicine, Nuclear Medicine, Oncology +17